Language

News topic

Product PHLOGENZYM

Current shortage notices for the product family PHLOGENZYM, structured by product, country and reporting period.

7 notices

← All shortages

What the PHLOGENZYM notices indicate for the supply chain

The 7 consolidated notices from Czechia are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Czechia

PHLOGENZYM 90MG/48MG/100MG TBL ENT 100 II

Active ingredient: TRYPSIN, KOMBINACE

View notice details →
Czechia

PHLOGENZYM 90MG/48MG/100MG TBL ENT 100 III

Active ingredient: TRYPSIN, KOMBINACE

View notice details →
Czechia

PHLOGENZYM 90MG/48MG/100MG TBL ENT 200 II

Active ingredient: TRYPSIN, KOMBINACE

View notice details →
Czechia

PHLOGENZYM 90MG/48MG/100MG TBL ENT 200 III

Active ingredient: TRYPSIN, KOMBINACE

View notice details →
Czechia

PHLOGENZYM 90MG/48MG/100MG TBL ENT 40 II

Active ingredient: TRYPSIN, KOMBINACE

View notice details →
Czechia

PHLOGENZYM 90MG/48MG/100MG TBL ENT 40 III

Active ingredient: TRYPSIN, KOMBINACE

View notice details →
Czechia

PHLOGENZYM 90MG/48MG/100MG TBL ENT 800

Active ingredient: TRYPSIN, KOMBINACE

View notice details →